People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Pharma, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Osteon Holdings, Inc. | — | Pharma | Growth/Late | $617.0M | $22.4B | 2018 |
| EP Global Production Solutions Investment, LLC | — | Business Services | Series C | $68.8M | $1.6B | 2019 |
MICHAEL LAGATTA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MICHAEL LAGATTA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| STEVEN A. WILLMANN | 2 | 4 |
| Joann Harris | 2 | 3 |
| Ken Murphy | 2 | 3 |
| ADAM FLISS | 2 | 2 |
| Kendall Garrison | 1 | 7 |
| John Schilling | 1 | 6 |
| CLIVE BODE | 1 | 4 |
| Jeffrey Binder | 1 | 3 |
| Todd Sisitsky | 1 | 3 |
| MARTIN A. DAVIDSON | 1 | 2 |
| Martin Davidson | 1 | 2 |
| STEPHEN D. ROSE | 1 | 1 |
| N/A TPG VIII EP SERIES HOLDINGS, L.P. | 1 | 1 |
| DAVID PETTY | 1 | 1 |
| WILLIAM PETTY | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.